We release the 2 issues of the FDA Fantastic Four in the Fall & Spring. What we are trying to help you know more about are the True Breakthrough medicines that the FDA has approved! We will take some artistic license on the release dates, we will apply the same 4-6 criteria whenever we rank, vote and choose! The Fabulous Four: Episode 1 - Fall 2023 includes Zurzuvae for post-partum depression, the September 13 COVID single virus vaccines, Mounjaro for diabetes and perhaps for weight loss and Aphexda aka motixafortide to help multiple myeloma patients.
a) Zurzuvae pill breaks through Postpartum Depression
b) ACIP approves monovalent COVID-19 vaccines September 13, 2023
c) Mounjaro approved May 2022 for diabetes and may get weight loss approval in 2023
d) Aphexda (motixafortide) was approved September 11, 2023 to help Bone Marrow transplant patients mobilize stem cells for Bone Marrow transplants to Multiple myeloma patients